文献速递心力衰竭与心肌病

尼日利亚围产期心肌病的临床特征与结局

Clinical Features and Outcomes of Peripartum Cardiomyopathy in Nigeria.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

该研究在尼日利亚14个中心连续纳入244例围产期心肌病(PPCM)患者,中位随访17个月。随访期间18.7%死亡,24.1%实现左室逆重构,22.6%实现左室完全恢复。基线LVEF<25%、低龄、低血压和心动过速独立预测死亡,而6个月时规律使用β受体阻滞剂与生存改善和功能恢复相关。

要点

  • 尼日利亚PPCM患者死亡率高达18.7%,左室逆重构和完全恢复率分别为24.1%和22.6%。
  • 基线LVEF<25%、年龄<20岁、低血压和心动过速是死亡的独立预测因素。
  • 6个月时规律使用β受体阻滞剂与降低死亡风险和促进左室功能恢复独立相关。

核心结论

  • 尼日利亚PPCM患者死亡率高,左室逆重构和完全恢复率低,多个基线变量可预测不良结局,规律使用β受体阻滞剂与晚期生存和左室功能恢复相关。

研究设计与样本

  • 在尼日利亚14个中心连续纳入244例PPCM患者(中位产后7个月),进行中位17个月(四分位距14-20个月)的结构化随访。

主要发现

  • 随访期间45例(18.7%)死亡,48例(24.1%)实现左室逆重构,45例(22.6%)实现左室完全恢复,18例(7.4%)住院。
  • 年龄<20岁(HR 2.40;95%CI 1.27-4.54)、低血压(HR 1.87;95%CI 1.02-3.43)、心动过速(HR 2.38;95%CI 1.05-5.43)和基线LVEF<25%(HR 2.11;95%CI 1.12-3.95)独立预测死亡。
  • 肥胖(HR 0.16;95%CI 0.04-0.55)和6个月随访时规律使用β受体阻滞剂(HR 0.20;95%CI 0.09-0.41)与死亡风险降低独立相关。
  • 基线LVEF<25%(HR 0.66;95%CI 0.47-0.92)和6个月随访时规律使用β受体阻滞剂(HR 1.62;95%CI 1.17-2.25)独立决定左室完全恢复的风险。
  • 观察到所有心腔的进行性逆重构。

关键数值与推荐

  • 左室逆重构定义为左室舒张末期内径<33 mm/m²且左室射血分数(LVEF)绝对增加≥10%。
  • 左室完全恢复定义为LVEF≥55%。

临床怎么用

  • 对于PPCM患者,应识别基线LVEF<25%、年龄<20岁、低血压和心动过速等高危因素,加强随访和管理。
  • 6个月时规律使用β受体阻滞剂可能与改善生存和左室功能恢复相关,可考虑在临床中优化β受体阻滞剂的使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nigeria has the highest incidence of peripartum cardiomyopathy (PPCM) in the world. However, data on PPCM-related outcomes are limited. OBJECTIVES: The purpose of this study was to examine the clinical profile, myocardial remodeling, and survival of patients with PPCM in Nigeria. METHODS: This study consecutively recruited 244 PPCM patients (median 7 months postpartum) at 14 sites in Nigeria and applied structured follow-up for a median of 17 months (interquartile range: 14 to 20 months). Left ventricular reverse remodeling (LVRR) was defined as the composite of left ventricular (LV) end-diastolic dimension <33 mm/m2 and absolute increase in left ventricular ejection fraction (LVEF) ≥10%. LV full recovery was defined as LVEF ≥55%. RESULTS: Overall, 45 (18.7%) patients died during follow-up. Maternal age <20 years (hazard ratio [HR]: 2.40; 95% confidence interval (CI): 1.27 to 4.54), hypotension (HR: 1.87; 95% CI: 1.02 to 3.43), tachycardia (HR: 2.38; 95% CI: 1.05 to 5.43), and LVEF <25% at baseline (HR: 2.11; 95% CI: 1.12 to 3.95) independently predicted mortality. Obesity (HR: 0.16; 95% CI: 0.04 to 0.55) and regular use of beta-blockers at 6-month follow-up (HR: 0.20; 95% CI: 0.09 to 0.41) were independently associated with reduced risk for mortality. In total, 48 patients (24.1%) achieved LVRR and 45 (22.6%) achieved LV full recovery. LVEF <25% at baseline (HR: 0.66; 95% CI: 0.47 to 0.92) and regular use of beta-blockers at 6-month follow-up (HR: 1.62; 95% CI: 1.17 to 2.25) independently determined the risk for LV full recovery. Progressive reverse remodeling of all cardiac chambers was observed. In total, 18 patients (7.4%) were hospitalized during the study. CONCLUSIONS: This is the largest study of PPCM in Africa. Consistent with late presentations, the mortality rate was high, whereas frequencies of LVRR and LV full recovery were low. Several variables predicted poor outcomes, and regular use of beta-blockers correlated with late survival and LV functional recovery.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Karaye KM, Sa'idu H, Balarabe SA, et al. Clinical Features and Outcomes of Peripartum Cardiomyopathy in Nigeria. J Am Coll Cardiol. 2020. PMID: 33183509. doi:10.1016/j.jacc.2020.09.540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。